Skip to content

Clinical trials

Completed Observational Hepatitis C trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatitis C Phase: Observational Status: Completed Clear all

255 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20015
20021
20032
20046
200518
200610
200710
20089
20098
20103
201115
201214
201311
201410
201522
201621
201720
201818
201915
20205
20216
20224
20235

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed255

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Merck Sharp & Dohme LLC18
AbbVie14
Bristol-Myers Squibb10
Gilead Sciences10
National Institutes of Health Clinical Center (CC)7
National Institute of Allergy and Infectious Diseases (NIAID)6
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)6
Icahn School of Medicine at Mount Sinai5
University of North Carolina, Chapel Hill5
Hospices Civils de Lyon4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatitis C255
Hepatitis C, Chronic48
HIV Infections27
Hepatitis B22
Acquired Immunodeficiency Syndrome20
Carcinoma, Hepatocellular14
Fibrosis11
Liver Cirrhosis9
Hepatitis8
Liver Diseases5

Trials

Showing 1 to 25 of 255. Each trial links to its page on Pharma Observatory.

155 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.